Study To Investigate The Safety And Metabolism Of GSK376501 In Overweight Subjects
Status:
Completed
Trial end date:
2007-12-01
Target enrollment:
Participant gender:
Summary
This study represents the second Phase 1 study with GSK376501 and the goal is to further
evaluate its safety and tolerability. The way the human body processes GSK376501 will also be
determined.